IQVIA Holdings Inc. IQV
- Market cap
- $45.3B
- P/E
- 33.3×
Follow IQV
IQVIA Holdings Inc. (IQV) Price to free cash flow
As of 25 September 2026, IQVIA Holdings Inc. (IQV) trades at a price to free cash flow of 19.9×. Over the past ten years it has ranged from 11.0× (May 2025) to 47.1× (June 2019); the current reading is higher than 30% of that period. That is below the Diagnostics & Research industry median of 34.0× and in line with the Healthcare sector median of 19.5×.
Price to free cash flow, daily
Annual
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 18.2× | 9.42% |
| FY2024 | 16.7× | (41.00%) |
| FY2023 | 28.2× | 17.07% |
| FY2022 | 24.1× | 2.79% |
| FY2021 | 23.5× | (8.08%) |
| FY2020 | 25.5× | (29.31%) |
| FY2019 | 36.1× | 21.29% |
| FY2018 | 29.8× | (17.67%) |
| FY2017 | 36.2× | 119.37% |
| FY2016 | 16.5× | (22.33%) |
Quarterly
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 14.2× | 8.39% |
| Mar 2026 | 13.1× | (28.08%) |
| Dec 2025 | 18.2× | 28.88% |
| Sep 2025 | 14.1× | 4.99% |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| DGX Quest Diagnostics Incorporated compare | 19.4× |
| IQV IQVIA Holdings Inc. | 19.9× |
| IDXX IDEXX Laboratories, Inc. compare | 33.1× |
| MTD Mettler-Toledo International, Inc. compare | 35.2× |
| A Agilent Technologies, Inc. compare | 38.4× |
| ILMN Illumina, Inc. compare | 44.9× |
| WAT Waters Corporation compare | 116× |
| NTRA Natera, Inc. compare | 702× |
| Diagnostics & Research industry median | 34.0× |
| Healthcare sector median | 19.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on IQV
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement